Lobbying activity

Q1

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice

View → Q1

TODD STRATEGY GROUP for NOVARTIS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q1

AMGEN, INC. for AMGEN INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q1

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

View → Q1

THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

CHRONIC CARE POLICY ALLIANCE for CHRONIC CARE POLICY ALLIANCE

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Health Issues

View → Q1

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q1

ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

WILLIAMS AND JENSEN, PLLC for PHRMA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues, Budget/Appropriations, Defense

View → Q1

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Animals, Budget/Appropriations

View → Q1

THE NICKLES GROUP, LLC for MERCK & CO. INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $70,000.00 income

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)

View → Q1

TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Trade (domestic/foreign)

View → Q1

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

THE NICKLES GROUP, LLC for NOVO NORDISK, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)

View → Q1

DLA PIPER LLP (US) for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues

View → Q1

NOVARTIS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → Q1

PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Health Issues

View → Q1

THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $20,000.00 income

Health Issues

View → Q1

CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy, Trade (domestic/foreign)

View → Q1

MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Trade (domestic/foreign), Taxation/Internal Revenue Code, Pharmacy, Copyright/Patent/Trademark

View → Q1

MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

MARSHALL & POPP, LLC for PFIZER, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Trade (domestic/foreign), Taxation/Internal Revenue Code, Pharmacy, Copyright/Patent/Trademark

View → Q1

MARSHALL & POPP, LLC for GENENTECH, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View →